-
Enabling the Drug Discovery and Delivery Interface (D3I)
Wednesday, November 14
2:00 pm – 4:30 pm
Symposium
ACPE #073-999-07-510-L04
The purpose of this symposium is to disseminate what D3I is all about and the role it plays in drug discovery today.
Moderator
Michael Hageman, Ph.D.
Bristol-Myers Squibb Company
Overview
Michael Hageman, Ph.D.
Bristol-Myers Squibb Company
Conceptual Origins of D3I
Ronald Borchardt, Ph.D.
University of Kansas
A Discovery Chemists Perspective on the Discovery and Preclinical Interface
Jochen Boehm, Ph.D.
Hoffmann-LaRoche, Inc.
Implementation of D3I Concepts in an Industrial Setting
Scott Grossman, Ph.D.
Bristol-Myers Squibb Company